Vir Biotechnology, Inc. (VIR)
Vir Biotechnology Market Cap: 820.84M for Jan. 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Vistagen Therapeutics, Inc. | 27.41M |
| Bristol Myers Squibb Co. | 108.77B |
| NovaBay Pharmaceuticals, Inc. | 715.11M |
| Palatin Technologies, Inc. | 14.87M |
| Theriva Biologics, Inc. | 8.469M |
Market Cap Related Metrics
| PS Ratio | 48.26 |
| Price to Book Value | 1.031 |
| Price | 5.90 |
| Earnings Yield | -61.36% |